CAD and cancer: were also able to demonstrate that ASS1 deficiency in cancer increases cytosolic aspartate levels leading to increased activation of the enzymatic complex CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, dihydroorotase complex) by upregulating its substrate availability and by increasing its phosphorylation by S6K1 through the mTOR pathway.